Carsten Stephan
Papers
3
Total Citations
133
H-Index
3
About
Carsten Stephan is a leading urological researcher whose work centers on improving prostate cancer diagnosis, prognosis, and surgical outcomes. His most impactful contribution lies in the validation of novel biomarkers, specifically the prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and the Prostate Health Index (PHI). His landmark 2014 multicentric European study, with 88 citations, demonstrated that these markers significantly predict pathologic outcomes, such as aggressive disease, in men undergoing radical prostatectomy, offering a more precise tool than traditional PSA testing alone. Beyond biomarkers, Stephan has made substantial contributions to surgical oncology, evidenced by his long-term analyses of laparoscopic radical prostatectomy. His 2012 study on continence and oncological outcomes (37 citations) provides critical benchmarks for minimally invasive techniques, while his work on positive surgical margins (8 citations) clarifies their impact on cancer recurrence. Through these efforts, Stephan has advanced both the biological understanding and clinical management of prostate cancer, helping to refine patient selection for surgery and improve prognostic accuracy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3